ScholarIQanswers from OpenAlex & ORCID
Vicente Valero
ResearcherPublications, citations & collaboration network
Vicente Valero is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vicente Valero have?
ScholarIQindexed works
Vicente Valero has 964 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vicente Valero have?
ScholarIQcitation count
Vicente Valero has 49,269 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vicente Valero?
ScholarIQh-index
Vicente Valero has an h-index of 118 in OpenAlex.
What is the i10-index of Vicente Valero?
ScholarIQi10-index
Vicente Valero has an i10-index of 411 in OpenAlex.
What is the ORCID of Vicente Valero?
ScholarIQorcid
The ORCID for Vicente Valero is on the source record.
What is the OpenAlex record for Vicente Valero?
ScholarIQopenalex
The OpenAlex for Vicente Valero is on the source record.
What are the most-cited papers on Vicente Valero?
ScholarIQmost cited works
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry M. Kuerer, Vicente Valero, Lina Assad, Anna W. Poniecka, Bryan T. Hennessy, Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobágyi, Lajos Pusztai
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee, Jane Fridlyand, Ayşegül A. Şahin, Roshan Agarwal, Corwin Joy, Wenbin Liu, David Stivers, Keith Baggerly, Mark Carey, Aňa Lluch, Carlos Monteagudo, Xiaping He, Victor Weigman, Cheng Fan, Juan Palazzo, Gabriel N. Hortobágyi, Laura K. Nolden, Nicholas J. Wang, Vicente Valero, Joe W. Gray, Charles M. Perou, Gordon B. Mills
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer
Kenneth R. Hess, K. Anderson, W. Fraser Symmans, Vicente Valero, Nuhad K. Ibrahim, Jaime Mejia, Daniel J. Booser, Richard L. Theriault, Aman U. Buzdar, Peter J. Dempsey, Roman Rouzier, Nour Sneige, Jeffrey S. Ross, Tatiana Vidaurre, Henry Gómez, Gabriel N. Hortobágyi, Lajos Pusztai
Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by <i>HER2</i> Immunophenotype and Gene Amplification
Andrew D. Seidman, Monica Fornier, Francisco J. Esteva, Lee K. Tan, Stamatina Kaptain, Ariadne M. Bach, Katherine S. Panageas, Crispinita D. Arroyo, Vicente Valero, Violante E. Currie, Teresa Gilewski, Maria Theodoulou, Mary Ellen Moynahan, Mark M. Moasser, Nancy T. Sklarin, Maura N. Dickler, Gabriella D’Andrea, Massimo Cristofanilli, Edgardo Rivera, Gabriel N. Hortobágyi, Larry Norton, Clifford A. Hudis